Deal Screening Mastery (Part 8 of 12): Not All $5B Markets Are Created Equal
How market structure determines whether strong execution can produce a venture-scale outcome.
Thinking Kat
A newsletter for people interested in life science leadership, product, talent, and ecosystem development.
Live Last read · last published · next check
Latest posts
Saves to your Listen queue, to pick up on another day or another device.
When VC Doesn’t Fit
Capital Strategy Beyond Equity for Life Science Companies
Deal Screening Mastery (Part 7 of 12): Proof, Not Motion
Telling Real Evidence from Mere Activity in Healthcare and Biotech Deals
Why Commercial Strategy Can’t Wait for Phase 3
A practical playbook for first-time therapeutics founders to link science, evidence, and market from Day 1
Deal Screening Mastery (Part 6 of 12): Follow the Path, Not the Pitch
Early Tests for Regulatory and Reimbursement Readiness
The Expert Middle: Navigating Your Career in a Converging Life Sciences Landscape
How to Define Your Value, Map Your Pathways, and Choose a Direction Without Locking Yourself In
Deal Screening Mastery (Part 5 of 12): "Why Now?" Is an Investment Question, Not a Marketing Slide
Learn How to Assess the Difference
When Mechanism Becomes Medicine
Statins, PCSK9, CRISPR, and the Next Wave of Heart Disease Prevention
Deal Screening Mastery (Part 4 of 12): Founder-Problem Fit
Moving Beyond the “Great Team vs Great Idea” Trap
Smart Risk for Smart Science Video Workshop
Leveraging Your Broker as a Strategic Partner